Literature DB >> 10925313

Autoantigen-specific CD4+CD28low T cell subset prevents autoimmune exocrinopathy in murine Sjögren's syndrome.

K Saegusa1, N Ishimaru, K Yanagi, N Haneji, M Nishino, M Azuma, I Saito, Y Hayashi.   

Abstract

Organ-specific autoimmune exocrinopathy resembling Sjögren's syndrome (SS) that spontaneously develops in NFS/sld mutant mice thymectomized 3 day after birth is dependent on Th1-type CD4+ T cells. We previously reported that a cleavage product of 120-kDa alpha-fodrin may be an important autoantigen in the pathogenesis of SS in both an animal model and the patients. We demonstrate that in an animal model of SS with overt exocrinopathy, a unique CD4+ T cell subset expressing CD28low is dramatically increased in spleen cells before the disease onset, but that the CD4+ T cells of diseased mice were virtually all CD28high. We found that the spleen cells in these mice before the disease onset showed a significant increase in autoantigen-specific T cell proliferation. Analysis of in vitro cytokine production by spleen cells indicated, before the disease onset, severely impaired production of IL-2 and IFN-gamma in the animal model, whereas high levels of IL-4 were observed. Expression of cytokine genes, including IL-4, IL-10, and TGF-beta, was detected in FACS-sorted CD4+CD28low T cells by RT-PCR analysis. Transfer of CD4+CD28low T cells into the animal model actually prevented the development of autoimmune lesions including autoantibody production. These results suggest that a CD4+CD28low T cell subset that is continuously activated by an organ-specific autoantigen may play a regulatory role in the development of organ-specific autoimmune disease in an animal model of SS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10925313     DOI: 10.4049/jimmunol.165.4.2251

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  Mouse Models of Primary Sjogren's Syndrome.

Authors:  Young-Seok Park; Adrienne E Gauna; Seunghee Cha
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

2.  Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.

Authors:  Kaoru Saegusa; Naozumi Ishimaru; Kumiko Yanagi; Rieko Arakaki; Kouichi Ogawa; Ichiro Saito; Nobuhiko Katunuma; Yoshio Hayashi
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

3.  Anti-inflammatory effects of rebamipide eyedrop administration on ocular lesions in a murine model of primary Sjögren's syndrome.

Authors:  Rieko Arakaki; Hiroshi Eguchi; Akiko Yamada; Yasusei Kudo; Akihiko Iwasa; Tserennadmid Enkhmaa; Fumika Hotta; Sayaka Mitamura-Aizawa; Yoshinori Mitamura; Yoshio Hayashi; Naozumi Ishimaru
Journal:  PLoS One       Date:  2014-05-27       Impact factor: 3.240

Review 4.  Immune checkpoint receptors in regulating immune reactivity in rheumatic disease.

Authors:  Sabrina Ceeraz; Elizabeth C Nowak; Christopher M Burns; Randolph J Noelle
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

5.  Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.

Authors:  Aya Ushio; Rieko Arakaki; Hiroshi Eguchi; Fumika Hotta; Akiko Yamada; Yasusei Kudo; Naozumi Ishimaru
Journal:  Int J Mol Sci       Date:  2017-06-06       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.